Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0270 Transporter Info
Gene Name	SLC30A10
Transporter Name	Zinc transporter 10
Gene ID	55532
UniProt ID	Q6XR72

Post-Translational Modification of This DT
Overview of SLC30A10 Modification Sites with Functional and Structural Information
Sequence	M G R Y S G K T C R L L F M L V L T V A F F V A E L V S G Y L G N S I A L L S D S F N M L S D L I S L C V G L S A G Y I A R R P T R G F S A T Y G Y A R A E V V G A L S N A V F L T A L C F T I F V E A V L R L A R P E R I D D P E L V L I V G V L G L L V N V V G L L I F Q D C A A W F A C C L R G R S R R L Q Q R Q Q L A E G C V P G A F G G P Q G A E D P R R A A D P T A P G S D S A V T L R G T S V E R K R E K G A T V F A N V A G D S F N T Q N E P E D M M K K E K K S E A L N I R G V L L H V M G D A L G S V V V V I T A I I F Y V L P L K S E D P C N W Q C Y I D P S L T V L M V I I I L S S A F P L I K E T A A I L L Q M V P K G V N M E E L M S K L S A V P G I S S V H E V H I W E L V S G K I I A T L H I K Y P K D R G Y Q D A S T K I R E I F H H A G I H N V T I Q F E N V D L K E P L E Q K D L L L L C N S P C I S K G C A K Q L C C P P G A L P L A H V N G C A E H N G G P S L D T Y G S D G L S R R D A R E V A I E V S L D S C L S D H G Q S L N K T Q E D Q C Y V N R T H F
PTM type	X-Phosphorylation X: Amino Acid

Phosphorylation
Serine	9 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A10			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	187
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A10 Serine 187 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC30A10			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	189
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A10 Serine 189 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC30A10			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	233
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A10 Serine 233 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC30A10			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	252
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A10 Serine 252 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC30A10			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	321
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A10 Serine 321 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC30A10			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	402
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A10 Serine 402 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC30A10			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	406
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A10 Serine 406 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC30A10			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	458
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A10 Serine 458 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC30A10			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	469
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A10 Serine 469 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A10			[1]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	196
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A10 Threonine 196 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A10			[3]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	263
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A10 Tyrosine 263 has the potential to affect its expression or activity.

References
1	Global Analyses of Selective Insulin Resistance in Hepatocytes Caused by Palmitate Lipotoxicity. Mol Cell Proteomics. 2018 May;17(5):836-849.
2	Systematic analysis of protein phosphorylation networks from phosphoproteomic data. Mol Cell Proteomics. 2012 Oct;11(10):1070-83.
3	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
4	A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples. J Proteome Res. 2012 Nov 2;11(11):5311-22.
5	TiO2 with Tandem Fractionation (TAFT): An Approach for Rapid, Deep, Reproducible, and High-Throughput Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):710-721.
6	Interrogating the hidden phosphoproteome. Proteomics. 2017 Mar;17(6):10.1002/pmic.201600437.
7	In situ sample processing approach (iSPA) for comprehensive quantitative phosphoproteome analysis. J Proteome Res. 2014 Sep 5;13(9):3896-904.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence